White coat adherence
White coat adherence, defined as improved patient adherence to treatment around clinic visits, can inaccurately suggest greater patient adherence than is otherwise demonstrated. Such patient behavior may negatively impact patient-provider decision-making, treatment planning, and, as a result, disease outcomes. For example, white coat adherence may artificially inflate blood serum levels leading a provider to mistakenly conclude that a patient is taking a therapeutic dose. With evidence of continued symptoms and without adequate understanding of patient adherence, providers may subsequently make unnecessary changes to the medication regimen and thus, adversely impact both disease control and medication side effects. Pharmacovigilance and Pharmacoepidemiology Journal offer a stage in Pharmacoepidemiology Researches and related subjects. Journal accepts leading forefront original research papers, review manuscripts, case reports and commentary in the field. Our target audience, readers and contributors are worldwide.